ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

RICHARD FOELLNER D.O.

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,018Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 93

$477K Total Retail Price of All Prescriptions

Rank: 11 out of 93

340 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 340 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

17% of this provider’s 340 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,327 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 505 462 1 5
OMEPRAZOLE 476 425 2 8
FUROSEMIDE 439 376 3 4
LISINOPRIL 411 349 4 3
SIMVASTATIN 348 325 5 2
WARFARIN SODIUM 277 274 6 12
METFORMIN HCL 253 178 7 7
POTASSIUM CHLORIDE 251 226 8 13
HYDROCHLOROTHIAZIDE 223 209 9 10
DIGOXIN 210 209 10 48
METOPROLOL TARTRATE 204 203 11 11
HYDROCODONE-ACETAMINOPHEN 174 108 S3 12 9
ALENDRONATE SODIUM 162 150 13 39
DONEPEZIL HCL 155 155 14 25
AMLODIPINE BESYLATE 140 139 15 6
TRAMADOL HCL 131 98 16 15
GABAPENTIN 129 107 17 17
CITALOPRAM HBR 126 122 18 45
ATENOLOL 119 113 19 16
ALLOPURINOL 112 94 20 29
CRESTOR 109 73 21 31
NAMENDA 108 108 22 55
TRIAMTERENE-HCTZ 103 91 23 29
SPIRONOLACTONE 100 96 24 67
GLIPIZIDE ER 90 89 25 56
PROPRANOLOL HCL 87 86 26 93
OXYBUTYNIN CHLORIDE ER 85 81 27 78
METOPROLOL SUCCINATE 84 72 28 14
MELOXICAM 79 52 29 42
TAMSULOSIN HCL 78 73 30 24
ISOSORBIDE MONONITRATE ER 77 64 31 62
PRAVASTATIN SODIUM 76 75 32 20
LOSARTAN POTASSIUM 76 64 32 26
GLIPIZIDE 72 56 34 41
AZITHROMYCIN 72 65 34 51
CARVEDILOL 71 60 36 23
RANITIDINE HCL 70 32 37 21
ACETAMINOPHEN-CODEINE 70 47 S3 37 65
ZOLPIDEM TARTRATE 69 63 39 40
PROAIR HFA 67 56 40 37
BUSPIRONE HCL 66 53 41 171
DILTIAZEM 24HR CD 66 66 41 165
DIOVAN 63 63 43 35
ESTRADIOL 62 46 R 44 226
CLONIDINE HCL 61 61 45 50
AMITRIPTYLINE HCL 59 36 R 46 61
FLUOXETINE HCL 59 53 46 82
OXYBUTYNIN CHLORIDE 53 49 48 95
HUMALOG 52 51 49 239
RISPERIDONE 52 52 49 54
CLOPIDOGREL 52 46 49 27
CARBIDOPA-LEVODOPA 50 50 52 113
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.